Remimazolam alleviates acute lung injury via translocator protein mediated inhibition of the NF-κB pathway
REM alleviated ALI by suppressing the NF-κB pathway via translocator protein, reducing inflammation and preserving alveolar-capillary barrier function. These findings highlight REM's potential for ARDS treatment.
Authors
- J. LI
- Ruohan Li (ORCID: https://orcid.org/0009-0000-7961-0087)
- Ya Gao (ORCID: https://orcid.org/0000-0003-3337-4116)
- Guorong Deng
- Xuting Jin
- Jiajia Ren
- Jingjing Zhang
- Chuchu Zhang
- Gang Wang
Institutions
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- European Journal of Pharmacology
- Published
- 2026-01-09
- DOI
- https://doi.org/10.1016/j.ejphar.2026.178540
- Primary Topic
- Immune Response and Inflammation
- Type
- article
- Field-Weighted Citation Impact
- 0.00